255
Views
11
CrossRef citations to date
0
Altmetric
Letters to the Editor

Rituximab-induced fatal interstitial pneumonitis: case report

, , , , &
Pages 546-548 | Received 04 Sep 2009, Accepted 28 Nov 2009, Published online: 28 Dec 2009

References

  • Sonet A, Bosly A. Rituximab and chemotherapy in diffuse large cell B cell lymphoma. Expert Rev Anticancer Ther 2009;9:719–726.
  • Burton C, Kaczmarski R, Jan-Mohamed R. Interstitial pneumonitis related to rituximab therapy. N Engl J Med 2003;348:2690–2691.
  • Liu X, Hong XN, Gu YJ, Wang BY, Luo ZG, Cao J. Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma. Leuk Lymphoma 2008;49:1778–1783.
  • Julien V, Perrin C, Peyrade F, Lemoigne F, Chichmanian RM, Blaive B. Alveolar hypoxemic interstitial pneumonia related to rituximab therapy. Rev Mal Respir 2004;21:407–410.
  • Lee Y, Kyung SY, Choi SJ, et al Two cases of interstitial pneumonitis caused by retuximab therapy. Korean J Intern Med 2006;21:183–186.
  • Kim KM, Kim HC, Jeon KN, et al Rituximab-CHOP induced interstitial pneumonitis in patients with disseminated extranodal marginal zoned B cell lymphoma. Yonsei Med J 2008;49:155–158.
  • Wagner SA, Mehta AC, Laber DA. Rituximab-induced interstitial lung disease. Am J Hematol 2007;82:916–919.
  • Chaumais MS, Garnier A, Chalard F, et al Fatal pulmonary fibrosis after rituximab administration. Pediatr Nephrol 2009;24:1753–1755.
  • Herishanu Y, Polliack A, Leider-Treo L, Grieff Y, Metser U, Naparstek E. Fatal interstitial pneumonitis related to rituximab-containing regimen. Clin Lymphoma Myeloma 2006;6:407–409.
  • van der Kolk LE, Grillo-Lopez AJ, Baars JW, Hack CE, van Oers MH. Complement activation plays a key role in the side-effects of rituximab therapy. Br J Haematol 2001;115:807–811.
  • Alho HS, Maasilta PK, Harjula AL, Hämmäinen P, Salminen J, Salminen US. Tumor necrosis factor alfa in a porcine bronchial model of obliterative bronchiolitis. Transplantation 2003;76:516–523.
  • Azoulay E, Herigault S, Levame M, et al Effect of granulocyte colony-stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosis. Crit Care Med 2003;31:1442–1448.
  • Adach K, Suzuki M, Sugimoto T, et al Granulocyte colony-stimulating factor exacerbates the acute lung injury and pulmonary fibrosis induced by intratracheal administration of bleomycin in rats. Exp Toxicol Pathol 2002;53:501–510.
  • Macartney C, Burke E, Elborn S, et al Bronchiolitis obliterans organizing pneumonia in a patient with non-Hodgkin's lymphoma following R-CHOP and pegylated filgrastim. Leuk Lymphoma 2005;46:1523–1526.
  • Donadieu J, Beaupain B, Rety-Jacob F, Nove-Josserand R. Respiratory distress and sudden death of a patient with GSDIb chronic neutropenia: possible role of pegfilgrastim. Haematologica 2009;94:1175–1177.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.